Merck (MRK) Receivables - Other (2009 - 2023)

Merck (MRK) has 12 years of Receivables - Other data on file, last reported at $473.0 million in Q1 2023.

• Receivables - Other for Q1 2023 came in at $473.0 million, down 34.21% year-over-year; the trailing twelve-month figure through Mar 2023 was $473.0 million (down 34.21% YoY), and the FY2022 annual result was $511.0 million, down 46.99% from the prior year.
• Receivables - Other fell to $473.0 million in Q1 2023 per MRK's latest filing, from $511.0 million in the prior quarter.
• Over five years, Receivables - Other peaked at $1.6 billion in Q2 2021 and troughed at $473.0 million in Q1 2023.
• A 3-year average of $860.4 million and a median of $684.0 million in 2022 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2023: Receivables - Other tumbled 59.5% in 2022, then plunged 34.21% in 2023.
• A 3-year view of Receivables - Other shows it stood at $964.0 million in 2021, then sank by 46.99% to $511.0 million in 2022, then dropped by 7.44% to $473.0 million in 2023.
• Business Quant data shows MRK's Receivables - Other at $473.0 million in Q1 2023, $511.0 million in Q4 2022, and $567.0 million in Q3 2022.